February 16, 2012 — Siemens Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for syngo Aortic ValveGuide, an integrated image processing software that helps cardiologists and cardiac surgeons prepare and perform transcatheter aortic valve replacement (TAVR).

February 16, 2012 — Velomedix Inc., a clinical stage medical device company, announced it has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to evaluate the use of rapid therapeutic hypothermia for the treatment of patients suffering an acute myocardial infarction (AMI or heart attack).

February 16, 2012 — Aptus Endosystems, a company developing advanced technology for endovascular aneurysm repair (EVAR), announced the start of ANCHOR; a global, multicenter, prospective post-market registry evaluating the use of the HeliFX aortic securement system in the treatment of aortic aneurysms.

February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter technology, announced that it will make its first detailed public presentation of preclinical data relating to its new V2 Renal Denervation System on Saturday, Feb. 18, 2012 at the TRenD Workshop 2012, in Frankfurt, Germany.

February 15, 2012 — CardioNet Inc. a wireless medical technology company announced the acquisition of ECG Scanning and Medical Services Inc.


February 15, 2012 — Medtronic Inc. announced the start of two clinical initiatives evaluating the broader, real-world clinical use of the company’s Symplicity renal denervation system across multiple conditions.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now